Hera BioLabs (“Hera”), a Lexington KY based contract research organization (CRO) serving the pharmaceutical and biotech markets announced it has been awarded a $400,000 Kentucky SBIR/STTR Matching Funds Grant to develop new products and services. Hera utilizes advanced gene editing technology to develop improved drug discovery tools for the $10B pre-clinical CRO outsourcing market.

The grant adds to Hera’s $774,000 National Institutes of Health (NIH) grant for a total of over $1.1 million in non-dilutive funding through the end of 2017. In order to qualify to apply for the SBIR/STTR Matching Funds Grant Hera was required to raise at least $400K in private investment funding.

 

Contact

Jack Crawford

jcrawford@herabiolabs.com